Anticoagulants, antiplatelets, and thrombolytics / edited by Shaker A. Mousa.

By:

Mousa, Shaker A

Contributor(s):

Mousa, Shaker A

Material type: Text

TextLanguage: English Series: Methods in molecular medicine ; 93Publication details: Totowa, N.J. : Humana Press, c2004.Description: x, 307 p. : ill. ; 24 cmISBN:

1588290832 (alk. paper)

Subject(s):

DDC classification:

615.718 22 MOU

NLM classification:

W1
QZ 170

Online resources:

Contents:

Highlights of latest advances in antithrombotics Antiplatelet, anticoagulant, and thrombolytic drug interactions Evaluation of platelet antagonists in in vitro flow models of thrombosis Heparin and low molecular weight heparin in thrombosis, cancer, and inflammatory diseases Are low molecular weight heparins the same? Antithrombotic drugs for the treatment of heparin-induced thrombocytopenia Laboratory methods for heparin-induced thrombocytopenia Factor Xa inhibitors Tissue factor/VIIa in thrombosis and cancer Tissue factor pathway inhibitor in thrombosis and beyond Cell adhesion molecules: potential therapeutic and diagnostic implications Development and applications of animal models of thrombosis A survey of venous thrombosis models Arixtra (fondaparinux sodium) Oral thrombin inhibitor ximelagatran Pharmacogenomics and coagulation disorders Guidelines for diagnosis and treatment of deep venous thrombosis and pulmonary embolism

Summary: "During the past decade, remarkable progress has been made in the development of new drugs to treat thrombotic and cardiovascular diseases, the number one cause of mortality worldwide. In Anticoagulants, Antiplatelets, and Thrombolytics, leading experts with established records of discovery and invention highlight the latest developments in antithrombotics and provide experimental methods for the discovery of new Read more...

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

Holdings
Item type	Current library	Collection	Call number	Status	Date due	Barcode
General Books	CUTN Central Library Medicine, Technology & Management	Non-fiction	615.718 MOU (Browse shelf(Opens below))	Available		38249

Highlights of latest advances in antithrombotics
Antiplatelet, anticoagulant, and thrombolytic drug interactions
Evaluation of platelet antagonists in in vitro flow models of thrombosis Heparin and low molecular weight heparin in thrombosis, cancer, and inflammatory diseases
Are low molecular weight heparins the same? Antithrombotic drugs for the treatment of heparin-induced thrombocytopenia
Laboratory methods for heparin-induced thrombocytopenia
Factor Xa inhibitors Tissue factor/VIIa in thrombosis and cancer Tissue factor pathway inhibitor in thrombosis and beyond Cell adhesion molecules: potential therapeutic and diagnostic implications
Development and applications of animal models of thrombosis A survey of venous thrombosis models Arixtra (fondaparinux sodium) Oral thrombin inhibitor ximelagatran Pharmacogenomics and coagulation disorders Guidelines for diagnosis and treatment of deep venous thrombosis and pulmonary embolism

"During the past decade, remarkable progress has been made in the development of new drugs to treat thrombotic and cardiovascular diseases, the number one cause of mortality worldwide. In Anticoagulants, Antiplatelets, and Thrombolytics, leading experts with established records of discovery and invention highlight the latest developments in antithrombotics and provide experimental methods for the discovery of new Read more...

Includes bibliographical references and index.

There are no comments on this title.

to post a comment.